MENU
XPH
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS
SPDR® S&P Pharmaceuticals ETF (XPH) Ownership - Who owns SPDR® S&P Pharmaceuticals ETF?
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U... Show more
Category: #Health
Profile
Category
Health
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com
Details
Group
Domestic Stock Funds
Category
Health
Net Assets
150324620.00
Fund Existence
about 19 years
Turnover
61.00
Capitalization
N/A
Yield
1.45
Total Expense Ratio
0.35
Investment Style
N/A
Risk (Beta)
0.74
Fundamentals
XPH
Net Assets
150M
Yield
1.45
Fund Existence
about 19 years
Total Expense Ratio
0.35
Turnover
61.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
0.74
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.35
Assets in Top Ten Holdings
95.6M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
150M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.35
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
43.00
Number of Net Holdings
43.00
Number of Short Holdings
N/A
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
37.60%
Gain YTD
-1.917
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Category Health
Profile
Fundamentals
Details
Category
Health
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com